Statistics
Zugriffszahlen seit März 2016. Zugriffszahlen aus dem Vorgängersystem werden nicht mitberücksichtigt.
Total Visits
| Views | |
|---|---|
| BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study | 80 |
Total Visits Per Month
| August 2022 | September 2022 | October 2022 | November 2022 | December 2022 | January 2023 | February 2023 | |
|---|---|---|---|---|---|---|---|
| BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study | 2 | 1 | 2 | 8 | 1 | 8 | 0 |
Top country views
| Views |
|---|
Top cities views
| Views |
|---|